» Articles » PMID: 20555073

Diffuse Large B-cell Non-Hodgkin's Lymphoma: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up

Overview
Journal Ann Oncol
Publisher Elsevier
Specialty Oncology
Date 2010 Jun 18
PMID 20555073
Citations 17
Authors
Affiliations
Soon will be listed here.
Citing Articles

Circulating Biomarkers for Therapeutic Monitoring of Anti-cancer Agents.

Janse van Rensburg H, Spiliopoulou P, Siu L Oncologist. 2022; 27(5):352-362.

PMID: 35285488 PMC: 9074993. DOI: 10.1093/oncolo/oyac047.


Diagnostic outcome and safety of CT-guided core needle biopsy for mediastinal masses: a systematic review and meta-analysis.

Lee H, Yun S, Kim J, Ryu C Eur Radiol. 2019; 30(1):588-599.

PMID: 31418086 DOI: 10.1007/s00330-019-06377-4.


The expression level of hsa-miR-146a-5p in plasma-derived exosomes of patients with diffuse large B-cell lymphoma.

Zare N, Eskandari N, Mehrzad V, Javanmard S J Res Med Sci. 2019; 24:10.

PMID: 30988678 PMC: 6421886. DOI: 10.4103/jrms.JRMS_507_18.


Chemotherapy and echocardiographic indices in patients with non-Hodgkin lymphoma: the ONCO-ECHO study.

Mizia-Stec K, Elzbieciak M, Wybraniec M, Rozewicz M, Bodys A, Braksator W Med Oncol. 2017; 35(1):14.

PMID: 29274027 PMC: 5741777. DOI: 10.1007/s12032-017-1075-2.


Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial.

Gonzalez-Barca E, Canales M, Salar A, Ferreiro-Martinez J, Ferrer-Bordes S, Garcia-Marco J Ann Hematol. 2016; 95(6):893-9.

PMID: 27025508 PMC: 4853453. DOI: 10.1007/s00277-016-2648-4.